Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Behçet's disease: immunopathologic and therapeutic aspects.

Robert Meador1, George Ehrlich, Joan M Von Feldt

  • 1Department of Rheumatology, Hospital of University of Pennsylvania, 3 Ravdin, Suite G, 3400 Spruce Street, Philadelphia, PA, USA.

Current Rheumatology Reports
|January 19, 2002
PubMed
Summary

Behçet

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structures of complete extracellular assemblies of type I and type II Oncostatin M receptor complexes.

Nature communications·2024
Same author

Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infection.

Science translational medicine·2024
Same author

Assay pH and critical reagent optimization in measuring concentrations of a monoclonal antibody and its target.

Bioanalysis·2022
Same author

The ALPHA Project: Establishing consensus and prioritisation of global community recommendations to address major challenges in lupus diagnosis, care, treatment and research.

Lupus science & medicine·2021
Same author

Inhibition of complement pathway activation with Pozelimab, a fully human antibody to complement component C5.

PloS one·2020
Same author

Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties.

Proceedings of the National Academy of Sciences of the United States of America·2019

Area of Science:

  • Immunology
  • Rheumatology
  • Systemic Inflammatory Diseases

Background:

  • Behçet's disease (BD) is a chronic systemic inflammatory disorder of unknown cause.
  • It is strongly linked to the human leukocyte antigen (HLA) B51.
  • Diagnosis relies on recurrent oral ulcerations, as specific lab tests are absent.

Purpose of the Study:

  • To provide a comprehensive overview of Behçet's disease.
  • To highlight recent advancements in its immunologic aspects.
  • To detail current and emerging treatment strategies.

Main Methods:

  • Literature review of Behçet's disease.
  • Analysis of immunologic associations.
  • Summary of therapeutic interventions.

Main Results:

  • Behçet's disease presents with recurrent oral ulcers and systemic inflammation.
  • The human leukocyte antigen (HLA) B51 is a significant genetic marker.
  • Treatment is tailored to disease severity and requires a multidisciplinary approach.

Conclusions:

  • Behçet's disease management necessitates a comprehensive understanding of its pathophysiology.
  • Latest immunologic insights are crucial for refining treatment protocols.
  • A multidisciplinary approach optimizes patient outcomes in Behçet's disease.

Related Experiment Videos